On Friday, Bayer said the permanent birth control device Essure would no longer be sold or distributed in the US for commercial reasons after 12/31/18. This came after FDA ’ s patient safety action in April restricting sale and distribution of the device and earlier agency actions

On Friday, Bayer said the permanent birth control device Essure would no longer be sold or distributed in the US for commercial reasons after 12/31/18. This came after FDA’s patient safety action in April restricting sale and distribution of the device and earlier agency actions

Source: Food and Drug Adminstration (FDA): CDRHNew - July 22, 2018 Category: Medical Devices Authors: ( at SGottliebFDA) Source Type: news